References
- Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford (UK): Oxford University Press; 2006.
- Briggs A. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health. 2005;8(1):1–2.
- National Institute for Health and Care Excellence. Methods for the development of NICE public health guidance. 3rd ed. London (UK): The Institute; 2012.
- Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force–6. Value Health. 2012;15(6):835–842.
- Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):781–798.
- Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: canada. 4th ed. Ottawa (ON): The Agency; 2017. p. 76.
- Institute For Clinical And Economic Review. ICER’s reference case for economic evaluations: principles and Rationale. 2018;15. https://icer-review.org/wp-content/uploads/2018/07/ICER_Reference_Case_July-2018.pdf
- Thompson KM, Graham JD. Going beyond the single number: using probabilistic risk assessment to improve risk management. Hum Ecol Risk Assess. 1996;2(4):1008–1034.
- Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985;5(2):157–177.
- Griffin S, Claxton K, Hawkins N, et al. Probabilistic analysis and computationally expensive models: necessary and required? Value Health. 2006;9(4):244–252.
- Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14(4):339–347.
- Elbasha EH, Chhatwal J. characterizing heterogeneity bias in cohort-based models. Pharmacoeconomics. 2015;33(8):857–865.
- Mercer AMD. A variant of Jensen’s Inequality. J Inequalities Pure Appl Math. 2003;4(4): 1-2. Article 73.
- Morris TP, White IR, Crowther MJ. Using simulation studies to evaluate statistical methods. Stat Med. 2019;38(11):2074–2102.
- Burton A, Altman DG, Royston P, et al. The design of simulation studies in medical statistics. Stat Med. 2006;25(24):4279–4292.
- Wisloff T, Hagen G, Hamidi V, et al. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010. Pharmacoeconomics. 2014;32(4):367–375.
- Kim DD, Wilkinson CL, Pope EF, et al. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res. 2017;17(6):615–623.
- European Network For Health Technology Assessment. Methods for health economic evaluations: A guideline based on current practices in Europe. 2015;100. https://www.eunethta.eu/wp-content/uploads/2018/03/Methods_for_health_economic_evaluations.pdf